Navigation Links
Varian Medical Systems Showcases Advanced Radiotherapy Systems for Treating Cancer at 2012 Arab Health Congress and Exhibition
Date:1/23/2012

DUBAI, United Arab Emirates, Jan. 23, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), the world leader in radiotherapy, is spotlighting its family of advanced treatment machines and integrated software solutions at the 2012 Arab Health Congress and Exhibition over the next four days. The Varian exhibit (Sheikh Saeed Hall, Booth No. S3-E40) focuses on latest developments and future innovations in Varian's complete line of medical linear accelerators – including the fast and precise TrueBeam system – along with Eclipse™ treatment planning software, ARIA® oncology information software, proton therapy systems, brachytherapy solutions, and its full range of X-ray tubes and digital image detectors.  

"We are excited to be able to showcase our advanced treatment, software and imaging systems at this prestigious event," says Rolf Staehelin, Varian's director international marketing for EMEA and APAC. "Varian is the clear market leader in radiotherapy and radiosurgery in the Gulf Corporate Council (GCC) countries and is at the forefront of technology advances that help clinicians benefit patients by delivering faster and more efficient treatments. We are looking forward to sharing our excitement about these developments with the radiation oncology community in this key region."

Designed to advance the treatment of lung, breast, prostate, gynaecologic, liver, head and neck, intracranial and other types of cancer, Varian's TrueBeam™ system was engineered from the ground up to treat tumors with unprecedented speed and accuracy. It features a multitude of technical innovations that dynamically synchronize imaging, patient positioning, motion management, and treatment delivery. With its High Intensity Mode, TrueBeam machines can deliver very high doses quickly and accurately, more than twice as fast as earlier generations of Varian technology.  

During the show, Varian is hosting a symposium on emerging technologies and advanced clinical applications at the American Hospital, Dubai's only radiotherapy center, with presentations followed by a tour of the facility. Key presentations include describing early treatments using Varian's RapidArc® radiosurgery at the American Hospital, as well as using ARIA oncology information software to create a paperless department there. For further information please download the symposium flyer.

As well as radiotherapy systems and software, the Varian booth also showcases the company's range of advanced X-ray tubes and digital image detectors for high quality filmless imaging, developed by the company's X-ray Products group.

Varian and the Middle East
Varian's long-term commitment to the Middle East includes a dedicated customer support services team -- with more than 20 installation, service and applications support personnel – as well as a regional sales office in Riyadh, a bonded warehouse facility in Bahrain and a spare parts bank in Saudi Arabia. The first clinical TrueBeam system in the Middle East is operating at the Azizia Royal Clinic in Riyadh, Saudi Arabia.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.

     


'/>"/>
SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening ... industry leaders in advanced audiology and hearing aid technology, ... ™, the world,s first internet connected hearing aid that ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... ,world firsts,: , TwinLink™ - the first ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
Breaking Medicine News(10 mins):